XTRA:RDCConsumer Retailing
Redcare Pharmacy (XTRA:RDC) Following H1 2026 Results, Is The Valuation Case Still Holding Up?
Redcare Pharmacy (XTRA:RDC) has drawn fresh attention after reporting half year 2026 results that combined higher sales with a wider net loss, while also confirming its full year revenue growth guidance.
See our latest analysis for Redcare Pharmacy.
Redcare Pharmacy’s recent half year update comes after a mixed share price pattern, with a 1 day share price return of 1.75% and a 90 day share price return of 38.85%, but a 1 year total shareholder return that declined 37.11%. This suggests short...